Mintilat

Medicinal product

(Invented) name

Mintilat

Active substance (s)

Metilsalicilatas

Strength

61,1 mg/g

Pharmaceutical form

tepalas

Route (s) of administration

vartoti ant odos

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

M02AC, Preparations with salicylic acid derivatives

Marketing authorisation holder

SIA Ingen Pharma, Latvija

Date of authorisation

2016-10-18

Date of renewal

2021-06-17

Documents

Mintilat_AR.pdf

3985 Mintilat tep_perreg2021-06-17.docx

3985 pakuotes lapelis_2021-06-17.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

1 g tepalo yra	1 g
Metilsalicilatas	61,1 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
63438	77878	1077878	tūbelė	20 g N1		Nereceptinis	LT/1/16/3985/001	Netiekiama	-	-	No	-	-
66699	81236	1081236	tūbelė	50 g N1		Nereceptinis	LT/1/16/3985/002	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-06-17	Perregistruotas
2016-10-18	Registruotas